Exelixis
EXEL
#1725
Rank
โ‚น810.74 B
Marketcap
โ‚น2,839
Share price
-1.16%
Change (1 day)
45.44%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Volume in USD (price x number of shares), data since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น9.86 M52.17%
2023โ‚น6.48 M-41.81%
2022โ‚น11.14 M-31.9%
2021โ‚น16.36 M-20.71%
2020โ‚น20.64 M303.63%
2019โ‚น5.11 M-70.5%
2018โ‚น17.33 M8.82%
2017โ‚น15.92 M-17.35%
2016โ‚น19.27 M-75.68%
2015โ‚น79.23 M19.37%
2014โ‚น66.37 M258.49%
2013โ‚น18.51 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น57.35 Mโ‚น99.79 M๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น11.17 Mโ‚น72.51 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น24.78 Mโ‚น98.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น43.55 Mโ‚น0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น62.92 Mโ‚น0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น81.31 Mโ‚น0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น48.65 Mโ‚น0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.26 Mโ‚น1.26 M๐Ÿ‡บ๐Ÿ‡ธ USA
N/Aโ‚น0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA